BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 6, Issue 8
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (8380)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.
Item 
Count 
PDF676
WORD358
HTML4141
Figures (1-3)256
Tables (1-5)249
 Sum=5680
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1455
Download1245
 Sum=2700
Aug 27, 2014 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Celikbilek M, Baskol M, Taheri S, Deniz K, Dogan S, Zararsiz G, Gursoy S, Guven K, Ozbakır O, Dundar M, Yucesoy M. Circulating microRNAs in patients with non-alcoholic fatty liver disease. World J Hepatol 2014; 6(8): 613-620 [PMID: 25232454 DOI: 10.4254/wjh.v6.i8.613]
URL: https://www.wjgnet.com/1948-5182/full/v6/i8/613.htm
Number Citing Articles
1
Peter Willeit, Philipp Skroblin, Stefan Kiechl, Carlos Fernández-Hernando, Manuel Mayr. Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease?. European Heart Journal 2016; 37(43): 3260 doi: 10.1093/eurheartj/ehw146
2
Changzhou Cai, Yiming Lin, Chaohui Yu. Circulating miRNAs as Novel Diagnostic Biomarkers in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Canadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/2096161
3
Yan Guo, Yanhua Xiong, Quanghu Sheng, Shilin Zhao, Julia Wattacheril, Charles Robb Flynn. A micro-RNA expression signature for human NAFLD progression. Journal of Gastroenterology 2016; 51(10): 1022 doi: 10.1007/s00535-016-1178-0
4
S. Georgiou, V. Pantazopoulou, Ema Anastasiadou. The Human Gut-Liver-Axis in Health and Disease. 2019; : 207 doi: 10.1007/978-3-319-98890-0_13
5
Lauren A. Newman, Michael J. Sorich, Andrew Rowland. Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine 2020; 9(7): 2032 doi: 10.3390/jcm9072032
6
Shengliang Xin, Qiao Zhan, Xiaofan Chen, Jinghang Xu, Yanyan Yu. Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysis. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01334-8
7
Ya-Di Wang, Liang-Liang Wu, Yun-Ni Mai, Kai Wang, Yi Tang, Qi-Yu Wang, Jiao-Yang Li, Li-Yan Jiang, Zhe-Zhen Liao, Can Hu, Yuan-Yuan Wang, Jing-Jing Liu, Jiang-Hua Liu, Xin-Hua Xiao. miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis. Metabolism 2023; 146: 155660 doi: 10.1016/j.metabol.2023.155660
8
Kimberley D. Bruce, Felino R. Cagampang. Parental Obesity: Intergenerational Programming and Consequences. 2016; : 255 doi: 10.1007/978-1-4939-6386-7_12
9
Albert J. Czaja. Epigenetic Aspects and Prospects in Autoimmune Hepatitis. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.921765
10
Sara Carpi, Simona Daniele, Jacqueline Fátima Martins de Almeida, Daniela Gabbia. Recent Advances in miRNA-Based Therapy for MASLD/MASH and MASH-Associated HCC. International Journal of Molecular Sciences 2024; 25(22): 12229 doi: 10.3390/ijms252212229
11
Jia-Hung Ye, Jung Chao, Ming-Ling Chang, Wen-Huang Peng, Hao-Yuan Cheng, Jiunn-Wang Liao, Li-Heng Pao. Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidation. Scientific Reports 2016; 6(1) doi: 10.1038/srep33102
12
Mehmet Nur KAYA, Ali KIRIK, Mehmet İÇLİ, Ayla YILDIZ, Ömer TOPRAK. Otoimmün Hepatit Hastalarında Karaciğer Fibrozisi ile MPV Arasındaki Korelasyon. Sakarya Medical Journal 2020;  doi: 10.31832/smj.752361
13
Andrey Turchinovich, Ancha Baranova, Oksana Drapkina, Alexander Tonevitsky. Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders. Frontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.01256
14
Prasanna K. Santhekadur, Divya P. Kumar. RISC assembly and post-transcriptional gene regulation in Hepatocellular Carcinoma. Genes & Diseases 2020; 7(2): 199 doi: 10.1016/j.gendis.2019.09.009
15
Johanna K. DiStefano, Glenn S. Gerhard. Circulating microRNAs in nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2016; 10(2): 161 doi: 10.1586/17474124.2016.1125290
16
Jie Liu, Yue Xiao, Xikun Wu, Lichun Jiang, Shurong Yang, Zhiming Ding, Zhuo Fang, Haiqing Hua, Mark Stephen Kirby, Jianyong Shou. A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitis. BMC Genomics 2018; 19(1) doi: 10.1186/s12864-018-4575-3
17
Víctor Micó, Laura Díez-Ricote, Lidia Daimiel. Nutrigenetics and Nutrimiromics of the Circadian System: The Time for Human Health. International Journal of Molecular Sciences 2016; 17(3): 299 doi: 10.3390/ijms17030299
18
Mingzhe Zhu, Qianlei Wang, Wenjun Zhou, Tao Liu, Lili Yang, Peiyong Zheng, Li Zhang, Guang Ji. Integrated analysis of hepatic mRNA and miRNA profiles identified molecular networks and potential biomarkers of NAFLD. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-25743-8
19
Sixu Li, Feng Xiong, Songbo Zhang, Jinghua Liu, Guangping Gao, Jun Xie, Yi Wang. Oligonucleotide therapies for nonalcoholic steatohepatitis. Molecular Therapy - Nucleic Acids 2024; 35(2): 102184 doi: 10.1016/j.omtn.2024.102184
20
Caroline M. Junker Mentzel, Ferhat Alkan, Helle Keinicke, Mette J. Jacobsen, Jan Gorodkin, Merete Fredholm, Susanna Cirera, Yun Zheng. Joint Profiling of miRNAs and mRNAs Reveals miRNA Mediated Gene Regulation in the Göttingen Minipig Obesity Model. PLOS ONE 2016; 11(11): e0167285 doi: 10.1371/journal.pone.0167285
21
Chao Sun, Jian-Gao Fan, Liang Qiao. Potential Epigenetic Mechanism in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2015; 16(3): 5161 doi: 10.3390/ijms16035161
22
Bo Zhu, Hao Wu, Kathryn S. Li, Shahram Eisa-Beygi, Bandana Singh, Diane R. Bielenberg, Wendong Huang, Hong Chen. Two sides of the same coin: Non-alcoholic fatty liver disease and atherosclerosis. Vascular Pharmacology 2024; 154: 107249 doi: 10.1016/j.vph.2023.107249
23
Emma Raitoharju, Ilkka Seppälä, Leo-Pekka Lyytikäinen, Jorma Viikari, Mika Ala-Korpela, Pasi Soininen, Antti J. Kangas, Melanie Waldenberger, Norman Klopp, Thomas Illig, Jaana Leiviskä, Britt-Marie Loo, Niku Oksala, Mika Kähönen, Nina Hutri-Kähönen, Reijo Laaksonen, Olli Raitakari, Terho Lehtimäki. Blood hsa-miR-122-5p and hsa-miR-885-5p levels associate with fatty liver and related lipoprotein metabolism—The Young Finns Study. Scientific Reports 2016; 6(1) doi: 10.1038/srep38262
24
Cheng Zhang, Ping Wang, Yongqiang Li, Changxin Huang, Wei Ni, Yidan Chen, Junping Shi, Gongying Chen, Xiangrong Hu, Meng Ye, Shiwei Duan, Kaifeng Wang. Role of MicroRNAs in the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. The Anatomical Record 2019; 302(2): 193 doi: 10.1002/ar.23954
25
Chang-Hai Liu, Javier Ampuero, Antonio Gil-Gómez, Rocío Montero-Vallejo, Ángela Rojas, Rocío Muñoz-Hernández, Rocío Gallego-Durán, Manuel Romero-Gómez. miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. Journal of Hepatology 2018; 69(6): 1335 doi: 10.1016/j.jhep.2018.08.008
26
Ting Zhang, Zhihong Yang, Praveen Kusumanchi, Sen Han, Suthat Liangpunsakul. MicroRNA in Regenerative Medicine. 2023; : 429 doi: 10.1016/B978-0-12-820719-2.00016-8
27
Yi-Jie Li, Brittney O Baumert, Nikos Stratakis, Jesse A Goodrich, Hao-Tian Wu, Jing-Xuan He, Yin-Qi Zhao, Max T Aung, Hong-Xu Wang, Sandrah P Eckel, Douglas I Walker, Damaskini Valvi, Michele A La Merrill, Justin R Ryder, Thomas H Inge, Todd Jenkins, Stephanie Sisley, Rohit Kohli, Stavra A Xanthakos, Andrea A Baccarelli, Rob McConnell, David V Conti, Lida Chatzi. Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity. World Journal of Gastroenterology 2024; 30(4): 332-345 doi: 10.3748/wjg.v30.i4.332
28
Jooho Lee, Yuri Kim, Simonetta Friso, Sang-Woon Choi. Epigenetics in non-alcoholic fatty liver disease. Molecular Aspects of Medicine 2017; 54: 78 doi: 10.1016/j.mam.2016.11.008
29
Rocío Gallego-Durán, Manuel Romero-Gómez. Epigenetic mechanisms in non-alcoholic fatty liver disease: An emerging field. World Journal of Hepatology 2015; 7(24): 2497-2502 doi: 10.4254/wjh.v7.i24.2497
30
Aida Zarfeshani, Sherry Ngo, Allan Sheppard. MicroRNA Expression Relating to Dietary-Induced Liver Steatosis and NASH. Journal of Clinical Medicine 2015; 4(11): 1938 doi: 10.3390/jcm4111938
31
Xiao Lin Liu, Hai Xia Cao, Jian Gao Fan. MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver disease. Journal of Digestive Diseases 2016; 17(11): 708 doi: 10.1111/1751-2980.12408
32
Vicneswarry Dorairaj, Siti Aishah Sulaiman, Nadiah Abu, Nor Azian Abdul Murad. Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis. Biomedicines 2021; 10(1): 15 doi: 10.3390/biomedicines10010015
33
Minakshi Rana, Manisha Saini, Rina Das, Sumeet Gupta, Tanishq Joshi, Dinesh Kumar Mehta. Circulating MicroRNAs: Diagnostic Value as Biomarkers in the Detection of Non-alcoholic Fatty Liver Diseases and Hepatocellular Carcinoma. MicroRNA 2023; 12(2): 99 doi: 10.2174/2211536612666230330083146
34
Mireia López-Riera, Isabel Conde, Guillermo Quintas, Laia Pedrola, Ángela Zaragoza, Judith Perez-Rojas, Mario Salcedo, Salvador Benlloch, José V. Castell, Ramiro Jover. Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-28854-4
35
Andre Broermann, Ramona Schmid, Ogsen Gabrielyan, Marlene Sakowski, Claudia Eisele, Sascha Keller, Michael Wolff, Patrick Baum, Birgit Stierstorfer, Jochen Huber, Bernhard K. Krämer, Berthold Hocher, Ruediger Streicher, Denis Delić. Exosomal miRNAs as Potential Biomarkers to Monitor Phosphodiesterase 5 Inhibitor Induced Anti-Fibrotic Effects on CCl4 Treated Rats. International Journal of Molecular Sciences 2020; 22(1): 382 doi: 10.3390/ijms22010382
36
Veronika Zubáňová, Zuzana Červinková, Otto Kučera, Vladimír Palička. The Connection between MicroRNAs from Visceral Adipose Tissue and Non-Alcoholic Fatty Liver Disease. Acta Medica (Hradec Kralove, Czech Republic) 2021; 64(1): 1 doi: 10.14712/18059694.2021.1
37
Ioana Rusu, Radu Pirlog, Paul Chiroi, Andreea Nutu, Vlad Radu Puia, Alin Cornel Fetti, Daniel Radu Rusu, Ioana Berindan-Neagoe, Nadim Al Hajjar. The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC. International Journal of Molecular Sciences 2022; 23(20): 12370 doi: 10.3390/ijms232012370
38
Fung Zhao. Obesity, Fatty Liver and Liver Cancer. Advances in Experimental Medicine and Biology 2018; 1061: 79 doi: 10.1007/978-981-10-8684-7_7
39
Elena Piccinin, Maria Arconzo, Giusi Graziano, Michele Vacca, Claudia Peres, Elena Bellafante, Gaetano Villani, Antonio Moschetta. Hepatic MicroRNA Expression by PGC-1α and PGC-1β in the Mouse. International Journal of Molecular Sciences 2019; 20(22): 5735 doi: 10.3390/ijms20225735
40
Hung-Yu Lin, Ya-Ling Yang, Pei-Wen Wang, Feng-Sheng Wang, Ying-Hsien Huang. The Emerging Role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in Modulating Oxidative Stress, Inflammation, and Beyond. Cells 2020; 9(4): 1041 doi: 10.3390/cells9041041
41
Gamze Guney Eskiler, Oguz Karabay, Mukaddes Tozlu, Ayhan Aydin, Kaan Furkan Hamarat, Umut Alkurt, Asuman Deveci Ozkan, Yasemin Gunduz. The Predictive Role of miRNAs in Hepatitis B Vaccine Response of Metabolic Dysfunction-Associated Steatotic Liver Disease Patients. Viruses 2024; 16(11): 1799 doi: 10.3390/v16111799
42
Monika Gjorgjieva, Cyril Sobolewski, Dobrochna Dolicka, Marta Correia de Sousa, Michelangelo Foti. miRNAs and NAFLD: from pathophysiology to therapy. Gut 2019; 68(11): 2065 doi: 10.1136/gutjnl-2018-318146
43
Stefania Di Mauro, Alessandra Scamporrino, Agnese Filippello, Antonino Di Pino, Roberto Scicali, Roberta Malaguarnera, Francesco Purrello, Salvatore Piro. Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD. International Journal of Molecular Sciences 2021; 22(21): 11905 doi: 10.3390/ijms222111905
44
Zixuan Zhang, Rachel Moon, James L. Thorne, J. Bernadette Moore. NAFLD and vitamin D: Evidence for intersection of microRNA-regulated pathways. Nutrition Research Reviews 2023; 36(1): 120 doi: 10.1017/S095442242100038X
45
Yuanjie Yu, Jie Zhu, Juan Liu, Mengjun Huang, Jin‐Xiang Wan. Identification of 8‐miRNAs as biomarkers for nonalcoholic fatty liver disease. Journal of Cellular Physiology 2019; 234(10): 17361 doi: 10.1002/jcp.28356
46
Siti Aishah Sulaiman, Nor I. A. Muhsin, Rahman Jamal. Regulatory Non-coding RNAs Network in Non-alcoholic Fatty Liver Disease. Frontiers in Physiology 2019; 10 doi: 10.3389/fphys.2019.00279
47
Dan-dan Wang, Xiu Chen, Dan-dan Yu, Su-jin Yang, Hong-Yu Shen, huan-huan Sha, Shan-liang Zhong, Jian-hua Zhao, Jin-hai Tang. miR-197: A novel biomarker for cancers. Gene 2016; 591(2): 313 doi: 10.1016/j.gene.2016.06.035
48
Shalini R. Dubey, Tester F. Ashavaid, Philip Abraham, Minal Umesh Paradkar. Factors influencing circulating microRNAs as biomarkers for liver diseases. Molecular Biology Reports 2022; 49(6): 4999 doi: 10.1007/s11033-022-07170-1
49
Kishor Pant, Senthil K. Venugopal. Circulating microRNAs: Possible role as non-invasive diagnostic biomarkers in liver disease. Clinics and Research in Hepatology and Gastroenterology 2017; 41(4): 370 doi: 10.1016/j.clinre.2016.11.001
50
Arash Veshkini, Abdollah Mohammadi-Sangcheshmeh, Ali A. Alamouti, Fatemeh Kouhkan, Abdolreza Salehi. Maternal supplementation with fish oil modulates inflammation-related MicroRNAs and genes in suckling lambs. Tropical Animal Health and Production 2020; 52(4): 1561 doi: 10.1007/s11250-019-02157-w
51
Xiaofang Zhang, Eralda Asllanaj, Masoud Amiri, Eliana Portilla‐Fernandez, Wichor M. Bramer, Jana Nano, Trudy Voortman, Qiuwei Pan, Mohsen Ghanbari. Deciphering the role of epigenetic modifications in fatty liver disease: A systematic review. European Journal of Clinical Investigation 2021; 51(5) doi: 10.1111/eci.13479
52
Bo Zhu, Siu-Lung Chan, Jack Li, Kathryn Li, Hao Wu, Kui Cui, Hong Chen. Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment. Frontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.742382
53
Chi-Yu Lai, Chiu-Ya Lin, Chia-Chun Hsu, Kun-Yun Yeh, Guor Mour Her. Liver-directed microRNA-7a depletion induces nonalcoholic fatty liver disease by stabilizing YY1-mediated lipogenic pathways in zebrafish. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2018; 1863(8): 844 doi: 10.1016/j.bbalip.2018.04.009
54
Marta Afonso, Pedro Rodrigues, André Simão, Rui Castro. Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma. Journal of Clinical Medicine 2016; 5(3): 30 doi: 10.3390/jcm5030030
55
Susanne Schuster, Daniel Cabrera, Marco Arrese, Ariel E. Feldstein. Triggering and resolution of inflammation in NASH. Nature Reviews Gastroenterology & Hepatology 2018; 15(6): 349 doi: 10.1038/s41575-018-0009-6
56
Qinghua Peng, Xiaoning Zhu, Yuanyuan Jiang, Mengyun Peng, Ding Zheng, Xiaodong Wang, Yoke Kqueen Cheah, Jing Wang. Evaluating the roles of microRNAs associated with nonalcoholic fatty liver disease in hepatocellular carcinoma tumorigenesis: a systematic review and network analysis. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1462513
57
Amir Zarrinpar, Shakti Gupta, Mano R Maurya, Shankar Subramaniam, Rohit Loomba. Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study. Gut 2016; 65(9): 1546 doi: 10.1136/gutjnl-2015-309456
58
Zhen He, Cheng Hu, Weiping Jia. miRNAs in non-alcoholic fatty liver disease. Frontiers of Medicine 2016; 10(4): 389 doi: 10.1007/s11684-016-0468-5
59
Halla M. Ragab, Wafaa M. Ezzat, Eman Mahmoud Hassan, Nabila Abd El Maksoud, Mie Afify, Mohamed D.E. Abd El-Maksoud, Wafaa Abd Elaziz. Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease. Journal of Genetic Engineering and Biotechnology 2023; 21(1): 13 doi: 10.1186/s43141-023-00467-z
60
Paola Dongiovanni, Marica Meroni, Miriam Longo, Silvia Fargion, Anna Ludovica Fracanzani. miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis. International Journal of Molecular Sciences 2018; 19(12): 3966 doi: 10.3390/ijms19123966
61
Fatemeh Amani, Amirhossein Sahebkar, Seyed Hamid Aghaee-Bakhtiari, Mohammadreza Farzanehfar, Saeedeh Askarian, Reza Kazemi Oskuee. Evaluation of the diagnostic role of circulating miR-16, miR-10b, and miR-21 expression in patients with nonalcoholic fatty liver disease. Gene Reports 2024; 36: 101964 doi: 10.1016/j.genrep.2024.101964
62
Jorge-Luis Torres, Ignacio Novo-Veleiro, Laura Manzanedo, Lucía Alvela-Suárez, Ronald Macías, Francisco-Javier Laso, Miguel Marcos. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease. World Journal of Gastroenterology 2018; 24(36): 4104-4118 doi: 10.3748/wjg.v24.i36.4104
63
Lucy Petagine, Mohammed Gulrez Zariwala, Vinood B Patel. Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments. World Journal of Gastroenterology 2023; 29(32): 4831-4850 doi: 10.3748/wjg.v29.i32.4831
64
Ruixian Huang, Xiaoyan Duan, Jangao Fan, Guangming Li, Baocan Wang. Role of Noncoding RNA in Development of Nonalcoholic Fatty Liver Disease. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/8690592
65
Bruno de Souza Goncalves, Avery Meadows, Duane G. Pereira, Raghav Puri, Sneha S. Pillai. Insight into the Inter-Organ Crosstalk and Prognostic Role of Liver-Derived MicroRNAs in Metabolic Disease Progression. Biomedicines 2023; 11(6): 1597 doi: 10.3390/biomedicines11061597
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345